Hayat Pharmaceutical Industries Co. PLC (ASE: HPIC)

Market Cap	23.94M
Revenue (ttm)	16.42M
Net Income (ttm)	2.95M
Shares Out	9.50M
EPS (ttm)	0.30
PE Ratio	8.42
Forward PE	n/a
Dividend	0.17 (6.55%)
Ex-Dividend Date	Apr 28, 2024

Volume	100
Open	2.520
Previous Close	2.520
Day's Range	2.520 - 2.520
52-Week Range	2.400 - 2.730
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 30, 2024

About HPIC

Hayat Pharmaceutical Industries Co. PLC engages in the manufacture and marketing of generic pharmaceutical products in Jordan. It offers products in various therapeutic areas, such as allergies; cardiovascular system; dermatology; gastrointestinal system; infectious disease; inner ear and balance; neurology; pain and inflammation; respiratory system; and vitamins and supplements, as well as men’s and women’s health products. The company was founded in 1994 and is based in Amman, Jordan.

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 236
• Stock Exchange: Amman Stock Exchange
• Ticker Symbol: HPIC

Financial Performance

In 2023, HPIC's revenue was 15.81 million, a decrease of -7.61% compared to the previous year's 17.11 million. Earnings were 2.33 million, a decrease of -34.04%.